THE
3002

Heading in chapter 30 — Pharmaceutical products

Human blood

Human Blood; Animal Blood Prepared Fortherapeutic, Prophylactic Or Diagnostic Uses; Antisera, Other Blood Fractions And Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines,toxins, Cultures Of Micro-

$621MIndia’s exports in 2025
186countries bought from India in 2025
63.5×change since 2013 ($9.8M)
3%of chapter 30 exports

India’s exports, year by year

US$, calendar years, all destinations combined. Source: UN Comtrade (India’s own reports).

Biggest buyers, 2025

  1. USA
  2. Netherlands
  3. Russian Federation
  4. United Arab Emirates
  5. Sri Lanka
  6. Viet Nam
  7. Algeria
  8. United Kingdom
  9. Colombia
  10. Poland

Ranked by value. Country-by-country figures are not shown.

What's inside 3002

5 codes India exports
3002.15Antisera and other blood fractions and modified immunological products, whether or not obtained by m…$369M in 2025 — 59% of the total3002.12Antisera and other blood fractions and modified immunological products, whether or not obtained by m$157M in 2025 — 25% of the total3002.13Antisera and other blood fractions and modified immunological products, whether or not obtained by m…$32M in 2025 — 5% of the total3002.14Antisera and other blood fractions and modified immunological products, whether or not obtained by m…$32M in 2025 — 5% of the total3002.90Human blood — other types$31M in 2025 — 5% of the total

Other codes in chapter 30

3004Medicaments$23B in 20253003Medicaments$353M in 20253006Pharmaceutical goods specified in note 4 to this chapter$302M in 20253001Glands and other organs for organo- therapeutic uses, dried,whether or not powdered$223M in 20253005Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters…$77M in 2025